Visualitza per autor "Zhou, Caicun"
Ara mostrant els elements 1-4 d 4
-
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Yang, James Chih-Hsin; Jänne, Pasi A.; Ramalingam, Suresh; Kim, Tae Min; Riely, Gregory; FELIP, ENRIQUETA; Zhou, Caicun (Taylor & Francis, 2023) -
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
Zhou, Caicun; Srivastava, Minu K; Xu, Hao; Wakelee, Heather; altorki, nasser; FELIP, ENRIQUETA (BMJ, 2023-10) -
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)
Nishio, Makoto; Ahn, Myung-Ju; Barlesi, Fabrice; Felip Font, Enriqueta; Mok, Tony; Zhou, Caicun; Ou, Sai-Hong (Elsevier, 2022-12) -
TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors
Nagasaka, Misako; Ohe, Yuichiro; Choi, Chang-Min; Yang, Nong; FELIP, ENRIQUETA; Zhou, Caicun; Liu, Geoffrey (Future Medicine, 2023-01)